Search for tag: "question"

2024 Salk Women & Science Program Awards

+19 More
From  Mike Jeffs

Biotech Sisterhood at the Salk Institute

Panel Discussion

+18 More
From  Mike Jeffs

Lora Hooper - Regulation of gut immunity by vitamin A and the microbiome

LJIC 2024

+19 More
From  Mike Jeffs

Maria Ines Matias - Unraveling the protein regulatory networks promoting cytotoxicity in CD4+ T cells

LJIC 2024

+18 More
From  Mike Jeffs

Sarah Kim - A CD25-CCR7 complex triggers an alternative IL-2 signaling pathway

LJIC 2024

+19 More
From  Mike Jeffs

Cody Elkins - Cellular cholesterol synthesis potentiates TCR signaling to promote the preferential clonal expansion of metabolically protective ST2-HI VAT TREG subsets

LJIC 2024

+19 More
From  Mike Jeffs

Mousa Vatanmakanian - Sex differences in adenosine deaminase activity are associated with disparities in SARS-CoV-2 innate immunity

LJIC 2024

+19 More
From  Mike Jeffs

Gerald Shadel - Mitochondrial Stress Signaling in Disease, Aging and Immunity

LJIC 2024

+18 More
From  Mike Jeffs

Shixin Ma - Nutrient-driven histone code determines exhausted COB+ T cell fates

LJIC 2024

+19 More
From  Mike Jeffs

lchiro Taniuchi - Essential roles of RUNX3/CBFB in regulating development and function of thetis APC cells

LJIC 2024

+19 More
From  Mike Jeffs

Suhas Sureshchandra - Tissue determinants of the human T cell receptor repertoire

LJIC 2024

+18 More
From  Mike Jeffs

Yingcong Li - Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans and mice

LJIC 2024

+19 More
From  Mike Jeffs

Vivien Maltez - Hijacking suppression: Converting Regulatory T Cells into Th 1 Effectors

LJIC 2024

+18 More
From  Mike Jeffs

Michael Elowitz - Many-to-many protein networks: computational modules for multicellular systems

LJIC 2024

+19 More
From  Mike Jeffs

Claire Murat - Wild-derived microbiota enhance the function of intratumor COB+ T cells

LJIC 2024

+19 More
From  Mike Jeffs

Takeya Masubuchi - Evolutionary fingerprint in rodent PO1 confers weakened activity and enhanced tumor immunity compared to human PO1

LJIC 2024

+18 More
From  Mike Jeffs